Dynamic multidetector computed tomography findings of hepatocellular carcinoma of hepatitis B virus-positive and -negative patients
Tóm tắt
The objective of this study was to retrospectively investigate and compare multidetector computed tomography findings of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-positive and -negative patients. Triphasic (arterial, portal venous, and delayed phases) dynamic multidetector computed tomography (CT) was performed in 83 patients with HCC, 48 of whom were HBV-positive. The diagnosis of HCC was established with typical CT imaging findings (68 patients) or histopathological evaluation (15 patients). Distribution of solitary, multiple, and diffuse HCC, portal/hepatic vein thrombosis, metastasis, and patients with high alpha-fetoprotein levels in the HBV-positive and -negative groups were compared using the Kolmogorov–Smirnov test. Lesion size, alpha-fetoprotein levels, arterial, portal, delayed enhancement, and washout of lesions were compared using the Student’s t-test. Hypervascular tumors were observed in 72 (87%) patients, and hypovascular tumors were found in 11 (13%) patients. The mean alpha-fetoprotein value of HBV-positive patients with HCC was significantly higher than the mean alpha-fetoprotein value of HBV-negative patients (P < 0.05). Portal/hepatic vein thrombosis and metastasis were more frequently observed in HBV-positive patients (P < 0.05). The frequencies of solitary, multiple, and diffuse lesions in HBV-positive and -negative patients were not significantly different (P > 0.05). The mean diameters, arterial, portal, and delayed phase attenuations, and washout of HCC were not significantly different (P > 0.05). Multidetector CT imaging findings of HCC in HBV-positive and -negative patients are alike. Portal/hepatic vein thrombosis and metastasis are more frequently observed in HBV-positive patients. Alpha-fetoprotein levels are higher in HBV-positive patients.
Tài liệu tham khảo
El-Serag HB, Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132: 2557–2576. 10.1053/j.gastro.2007.04.061
Ozer B, Serin E, Yilmaz U, Gümürdülü Y, Saygili OB, Kayaselçuk F, Boyacioğlu S: Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Turk J Gastroenterol 2003, 14: 85–90.
Ishikawa T: Clinical features of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2010, 16: 2463–2467. 10.3748/wjg.v16.i20.2463
Blonski W, Kotlyar DS, Forde KA: Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010, 16: 3603–3615. 10.3748/wjg.v16.i29.3603
Prasad SR, Wang H, Rosas H, Menias CO, Narra VR, Middleton WD, Heiken JP: Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005, 25: 321–331. 10.1148/rg.252045083
Baron RL, Oliver JH 3rd, Dodd GD 3rd, Nalesnik M, Holbert BL, Carr B: Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996, 199: 505–511.
Mitsuzaki K, Yamashita Y, Ogata I, Nishiharu T, Urata J, Takahashi M: Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR Am J Roentgenol 1996, 167: 753–757. 10.2214/ajr.167.3.8751695
Hwang GJ, Kim MJ, Yoo HS, Lee JT: Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 1997, 202: 383–388.
Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, Oi H, Sakon M, Nakamura H: Optimal phase of dynamic CT for detecting hepatocellular carcinoma: evaluation of unenhanced and triple-phase images. Abdom Imaging 1999, 24: 473–480. 10.1007/s002619900543
Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, Valleur P, Rymer R: Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 2004, 231: 413–420. 10.1148/radiol.2312021639
Monzawa S, Ichikawa T, Nakajima H, Kitanaka Y, Omata K, Araki T: Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol 2007, 188: 147–153. 10.2214/AJR.05.0512
Iannaccone R, Laghi A, Catalano C, Rossi P, Mangiapane F, Murakami T, Hori M, Piacentini F, Nofroni I, Passariello R: Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005, 234: 460–467. 10.1148/radiol.2342031202
Kim KE, Park MS, Bentley-Hibbert S, Baek SE, Kim YC, Kim MJ, Kim KW, Auh YH: Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis. Abdom Imaging 2012, 37: 591–594. 10.1007/s00261-011-9799-5
Butt AS, Hamid S, Wadalawala AA, Ghufran M, Javed AA, Farooq O, Ahmed B, UI Haq T, Jafri W: Hepatocellular carcinoma in Native South Asian Pakistani population; trends, clinico-pathological characteristics & differences in viral marker negative & viral-hepatocellular carcinoma. BMC Res Notes 2013, 6: 137. 10.1186/1756-0500-6-137
Daniele B, Bencivenga A, Megna AS, Tinessa V: Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004, 127: S108-S112. 10.1053/j.gastro.2004.09.023
Trevisani F, D’Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M: Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001, 34: 570–575. 10.1016/S0168-8278(00)00053-2
Tanabe G, Nuruki K, Baba Y, Imamura Y, Miyazono N, Ueno K, Arima T, Nakajyou M, Aikou T: A comparison of hepatocellular carcinoma associated with HBV or HCV infection. Hepatogastroenterology 1999, 46: 2442–2446.
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35: 421–430. 10.1016/S0168-8278(01)00130-1
Huang GT, Sheu JC, Yang PM, Lee HS, Wang TH, Chen DS: Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma—a study based on 420 patients. J Hepatol 1996, 25: 334–338. 10.1016/S0168-8278(96)80120-6
Bruix J, Sherman M, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: an update. Hepatology 2011, 53: 1020–1022. 10.1002/hep.24199